project id: TCGA-HNSC; case submitter id: TCGA-BB-A5HU; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.79; rna integrity number: 9.4; age at index: 47; days to birth: -17502; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1965; age at diagnosis: 17502; ajcc clinical m: M0; ajcc clinical n: N2b; ajcc clinical stage: Stage IVA; ajcc clinical t: T4; ajcc pathologic m: M0; ajcc pathologic n: N2b; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T4; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 782.0; icd 10 code: C06.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Mouth, NOS; synchronous malignancy: Yes; tissue or organ of origin: Mouth, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Yes; is ffpe: false; composition: Not Reported; days to collection: 246; days to sample procurement: 0; initial weight: 160.0; portion submitter id: TCGA-BB-A5HU-01A-11; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 10.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 60.0; percent tumor nuclei: 70.0;